Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.

By A. Al-Ahmad, W. Rand, G. Manjunath, M. Konstam, D. Salem, A. Levey, M. Sarnak. Journal of the American College of Cardiology, 2001

747 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure (2005, neutral): “311 4/29 ( 14 ) 15/74 (20) 325 2/42 (5) 15/85 (18) 326 9/102 (9) 36/203 (18) VMAC 45/216 (21) 74/273 (27) Precedent 9/83 (11) 29/162 (18) Totals 69/472 (15) 169/797 (21)”
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. (2007, background): “any laboratory findings have been shown to be associated ith outcome in heart failure (4,5).”
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. (2002, methodology): “although the relationship between anemia and adverse outcomes has been described in patients with ESRD (7) and patients with asymptomatic left ventricular dysfunction or mild to moderate HF (2), our study extends this finding to patients with advanced HF.”